Improving Outcomes in MDS and MPN: Tailoring Treatment Based on Patient- and Disease-Specific Factors


Official Links

Estimated Turnout

upto 100
Based on previous editions


Dec 2021
+1 more edition


Claim event to edit details

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing .. Read more medical education for physicians. Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity is supported by educational grants from Agios Pharmaceuticals, Inc.; Astex Pharmaceuticals, Inc.; Bristol Myers Squibb; Gilead Sciences, Inc.; Novartis Pharmaceuticals Corporation; Taiho Oncology, Inc.; and Takeda Oncology. This online, on-demand activity brings together renowned experts in MPN and MDS. In this educational program these experts use a case-based format to discuss the latest data regarding management of these malignancies, share perspectives and best practices, and forecast applications to address key clinical challenges and questions regarding selecting individualized and optimal therapies for patients with MPN and MDS with subtypes spanning the spectrum of care, including low-risk and high-risk MDS, myelofibrosis, and polycythemia vera. Safety considerations, including management of underlying and treatment-related anemia, are also addressed.

  • Share your Experience
  • Organizer
Logo Follow Company

Physicians Education ResourceRenowned

USA109 Total Events / 37 Upcoming Events

More Events From The Organizer